PHAR
Pharming Group·NASDAQ
--
--(--)
--
--(--)
7.08 / 10
Outperform
Analyst sentiment is highly bullish: two analysts issue Strong Buy and Buy, both with 100% historical win rates. Fund‑flow metrics are strong (7.9/10), showing net inflows across most investor sizes, though medium and large blocks show slight outflows. Overall sentiment leans positive.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-13
InstitutionOppenheimer
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for PHAR?
- PHAR holds a Bullish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.08/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
